Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
67 * ! | Sun, 8/4/2013, 4:00 PM - 5:50 PM | CC-512e | |
Enhanced Design, Analysis, Modeling, and Interpretation of QT Studies — Topic Contributed Papers | |||
Biopharmaceutical Section , Biometrics Section | |||
Organizer(s): Donna Kowalski, Astellas Pharma Global Development, Inc. | |||
Chair(s): Donna Kowalski, Astellas Pharma Global Development, Inc. | |||
4:05 PM | Can Pooled SAD/MAD Studies Give Early Indication of Possible QTc Signal? — Kimberly Crimin, Novartis Pharmaceutical Corporation | ||
4:25 PM | Sensitivity Analyses for PK-QTc Modeling: Nonlinearity and Hysteresis — Matthew Hutmacher, Ann Arbor Pharmacometrics Group | ||
4:45 PM | Notably More Powerful Analyses of Thorough QT Crossover Trials — Devan Mehrotra, Merck ; Li Fan, Merck Research Laboratories ; Xiaodong Li, Bristol Myers Squibb | ||
5:05 PM | Baseline Adjustment in Thorough QT Studies — Kaifeng Lu, Forest Laboratories | ||
5:25 PM | Floor Discussion |
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.